- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT07728305
Relative Age and Passing Performance in Pre-adolescent Football Players (RAE-LSPT)
Relative Age and Passing Performance in Pre-adolescent Football Players: A Cross-Sectional Study Using the Loughborough Soccer Passing Test
Visão geral do estudo
Status
Condições
Descrição detalhada
Annual age grouping in youth football can create a relative age effect, characterised by the over-representation of players born earlier in the selection year. This pattern is often attributed to temporary developmental advantages, but it is unclear whether earlier-born pre-adolescent players also demonstrate superior technical performance.
The study used a cross-sectional observational design in a youth football development programme in Bello, Colombia. The source cohort contained 61 participant records. Birth month was used to classify players into four relative-age quarters: Q1 (January-March), Q2 (April-June), Q3 (July-September) and Q4 (October-December), and into two semesters: H1 (January-June) and H2 (July-December).
Passing performance was measured with the Loughborough Soccer Passing Test. Players were scheduled to complete two trials separated by five minutes. Each trial comprised 16 externally cued passes to four colour-coded target areas. Movement time was adjusted by adding penalties for inaccurate execution or protocol violations and subtracting bonuses for striking the central target strip. Lower total performance time indicated better performance. The primary technical outcome was the mean total performance time across available trials. Sensitivity outcomes included Trial 1 and the best trial.
The primary analysis estimated the association between birth month and LSPT total performance time after adjustment for birth cohort. Additional analyses examined representation by quarter and semester and agreement between the two LSPT trials. Data collection was completed in 2017. The study is being registered retrospectively in 2026 to improve transparency and support public sharing of the anonymised dataset and analysis materials.
Tipo de estudo
Inscrição (Real)
Contactos e Locais
Locais de estudo
-
-
Antioquia
-
Guarne, Antioquia, Colômbia, 054080
- Tecnológico de Antioquia
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
- Filho
Aceita Voluntários Saudáveis
Método de amostragem
População do estudo
Descrição
Inclusion Criteria:
- Registered or actively participating in the selected youth football development programme in Bello, Colombia during the assessment period.
- Date of birth available in the programme roster.
- Able to undertake the football passing assessment.
- Written parent or legal guardian consent and child assent.
Exclusion Criteria:
- Acute injury, illness or medical restriction preventing safe completion of the LSPT [retain only if this was an actual criterion].
- Unable to complete the required familiarisation or test procedure.
- Missing date-of-birth information.
- No valid LSPT trial available for inclusion in the primary analytical sample.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
Coortes e Intervenções
Grupo / Coorte |
|---|
|
Group 1
Q1 - Players born from January to March
|
|
Group 2
Q2 - Players born from April to June
|
|
Group 3
Q3 - Players born from July to September
|
|
Group 4
Q4 - Players born from October to December
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Mean LSPT total performance time
Prazo: Day 1
|
Mean of all available LSPT trial total performance times, expressed in seconds.
For each trial, total performance time was calculated as movement time plus penalty time minus bonus time.
Lower values indicate better performance.
|
Day 1
|
|
Number of participants in each relative-age quarter
Prazo: Baseline
|
Count of participants classified as Q1 (January-March), Q2 (April-June), Q3 (July-September) or Q4 (October-December), based on the date of birth recorded in the programme roster.
|
Baseline
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
LSPT Trial 1 total performance time
Prazo: Day 1
|
Trial 1 movement time plus penalty time minus bonus time, expressed in seconds.
|
Day 1
|
|
Best LSPT total performance time
Prazo: Day 1
|
Lowest total performance time recorded across the participant's available LSPT trials, expressed in seconds.
Two trials were scheduled five minutes apart.
|
Day 1
|
|
Number of participants in each relative-age semester
Prazo: Baseline
|
Count of participants classified as H1 (January-June) or H2 (July-December), based on the date of birth recorded in the programme roster.
|
Baseline
|
|
Difference between Trial 2 and Trial 1 total performance time
Prazo: Day 1
|
Trial 2 total performance time minus Trial 1 total performance time, expressed in seconds, among participants who completed both trials.
The two trials were scheduled five minutes apart.
|
Day 1
|
Colaboradores e Investigadores
Patrocinador
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Outros números de identificação do estudo
- RAE-LSPT-2017-01
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Descrição do plano IPD
Prazo de Compartilhamento de IPD
Critérios de acesso de compartilhamento IPD
Tipo de informação de suporte de compartilhamento de IPD
- PROTOCOLO DE ESTUDO
- SEIVA
- ANALYTIC_CODE
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .